India to United Kingdom Pharmaceutical Export (2026) — $1.2B, 610 Suppliers | TransData Nexus

India to United Kingdom Pharmaceutical Export (2026) — $1.2B, 610 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to United Kingdom

#	Formulation	Value	Share
1	Mebeverine Tablets 135mg(mebeverine 135	$42.4M	3.4%
2	Pharmaceutical Products Colesevelam Hcl625mg Fctab 180s Hdpe UK (inv.qty.5265x1…	$31.9M	2.6%
3	Pharmaceutical Products- Co-codamol 15mg500mg Tablets Exempted Material(w/o Was…	$29.3M	2.4%
4	Carbocisteine Capsules 375 Mg, Hard (8x1	$28.8M	2.3%
5	Co-codamol 30mg/500mg Tablets (caplet) (eachtab Codeine Phosphate Hemihydrate P…	$27.0M	2.2%
6	Gabapentin 300mg Hard Capsules (batch No	$22.2M	1.8%
7	Levetiracetam Tablets 500mg(levetiraceta	$19.2M	1.5%
8	Pharmaceutical Products- Co-codamol 15mg500mg Tablets Exempted Material (w/o Wa…	$18.4M	1.5%
9	Ibuprofen 200mg Caplet 12x16 Bli Pk -total 24433 Pack of 192 Tablets Total 4691…	$15.0M	1.2%
10	Paracetamol 500 MG Tablets (2x4`s)	$13.6M	1.1%
11	Paracetamol 500 MG Tablets (2x8`s)	$12.6M	1.0%
12	Clarithromycin Film - Coated Tablets 250	$11.3M	0.9%
13	Fluoxetine 20mg Capsules (3x10s) - Tax I	$10.4M	0.8%
14	Ibuprofen 200mg Caplet Tablets 12x16 Bli Pk--total 16419 Pack of 192 Tablets To…	$10.1M	0.8%
15	Pregabalin Capsules 75 Mg(pregabalin Mil	$9.9M	0.8%

India exports 17+ pharmaceutical formulations to United Kingdom with a combined trade value of $1.2B. Key products include Gabapentin ($22.2M), Ibuprofen ($15.0M), Paracetamol ($13.6M), Clarithromycin ($11.3M), Fluoxetine ($10.4M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 40,891 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to United Kingdom Trade Routes

1Gabapentin$22.2M 2Ibuprofen$15.0M 3Paracetamol$13.6M 4Clarithromycin$11.3M 5

Top Indian Exporters to United Kingdom

1Aurobindo Pharma Ltd

$142.0M

2Wockhardt Limited

$113.8M

3Micro Labs Limited

$79.7M

4Sanofi India Limited

$76.9M

5Emcure Pharmaceuticals Limited

Port Analysis — India to United Kingdom Pharmaceutical Shipments

Indian Export Ports

NHAVA SHEVA SEA0.7%

NHAVA SHEVA SEA (INNSA1)10.9%

VIZAG SEA1.2%

CHENNAI AIR0.4%

KAMARAJAR PORT1.3%

United Kingdom Import Ports

LONDON GATWAY PORT21.3%

LONDON - HEATHROW23.3%

Felixstowe10.6%

Southampton6.7%

FELIXSTOWE12.0%

Trade Statistics

Total Value$1.2B

Shipments40,891

Indian Exporters610

United Kingdom Buyers1615

Avg Shipment$30K

Products24,175

Other Destinations

United States$8.8B Canada$1.1B France$970.4M Australia

Last updated: March 28, 2026

India–United Kingdom Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and the United Kingdom has experienced significant growth over the past decades. In 2024, India exported pharmaceutical products valued at $760.17 million to the UK, marking a substantial increase from previous years. This upward trajectory reflects India's expanding role as a global supplier of finished pharmaceutical formulations, catering to the UK's diverse healthcare needs.

Key milestones in this bilateral trade include the establishment of robust supply chains and the adoption of international quality standards by Indian manufacturers. The UK's reliance on imported pharmaceuticals, particularly generics, has further bolstered this trade relationship. The Medicines and Healthcare products Regulatory Agency (MHRA) has played a pivotal role in facilitating the entry of Indian pharmaceutical products into the UK market by ensuring compliance with stringent regulatory requirements.

2India's Market Position

India holds a significant position in the UK's pharmaceutical import landscape. In 2024, pharmaceutical products accounted for $760.17 million of India's total exports to the UK, underscoring the sector's importance. This positions India as a key supplier, especially in the generic medicines segment, which aligns with the UK's strategic focus on cost-effective healthcare solutions.

Recent Developments

United Kingdom Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to export to the UK must navigate the MHRA's registration process. This involves submitting a comprehensive dossier, typically in the Common Technical Document (CTD) or electronic Common Technical Document (eCTD) format, which includes detailed information on the product's quality, safety, and efficacy. The MHRA assesses these submissions to ensure compliance with UK standards.

The registration timeline can vary. Standard applications may take up to 60 working days for processing, excluding any time required for additional information or data. If an inspection of the manufacturing facility is necessary, the process may extend to 90 days.

2GMP & Facility Requirements

The UK mandates that all pharmaceutical products imported into its market adhere to Good Manufacturing Practice (GMP) standards. Indian manufacturers must ensure their facilities comply with these standards, which are evaluated during the MHRA's inspection process. The MHRA conducts inspections to verify compliance with GMP, and mutual recognition agreements may facilitate the acceptance of inspections conducted by recognized authorities in India.

3Import Documentation

To import pharmaceutical products into the UK, Indian exporters must provide several key documents:

Certificate of Pharmaceutical Product (CPP): Confirms that the product is authorized for sale in the exporting country.

Certificate of Analysis (CoA): Details the product's composition and quality control measures.

Good Manufacturing Practice (GMP) Certificate: Demonstrates that the manufacturing facility adheres to GMP standards.

These documents are essential for customs clearance and regulatory compliance. Additionally, adherence to the UK's customs procedures, including accurate labeling and packaging, is crucial for the smooth importation of pharmaceutical products.

EXPORT_TRENDS

TransData Nexus Research · United Kingdom regulatory databasesMar 2026

FAQ — India to United Kingdom Pharmaceutical Trade

What is the total value of India's pharmaceutical export to United Kingdom?

India exported pharmaceuticals worth $1.2B to United Kingdom across 40,891 verified shipments.

Who are the top Indian pharmaceutical exporters to United Kingdom?

1. AUROBINDO PHARMA LTD — $142.0M. 2. WOCKHARDT LIMITED — $113.8M. 3. MICRO LABS LIMITED — $79.7M. Total: 610 suppliers.

Which companies in United Kingdom import pharmaceuticals from India?

1. WOCKHARDT UK LIMITED — $121.1M. 2. MILPHARM LIMITED, — $118.0M. 3. ALLOGA UK AP7 — $88.6M. 1615 buyers total.

What pharmaceutical products does India export most to United Kingdom?

1. Mebeverine Tablets 135mg(mebeverine 135 ($42.4M, 3.4%); 2. Pharmaceutical Products Colesevelam Hcl625mg Fctab 180s Hdpe UK (inv.qty.5265x1… ($31.9M, 2.6%); 3. Pharmaceutical Products- Co-codamol 15mg500mg Tablets Exempted Material(w/o Was… ($29.3M, 2.4%); 4. Carbocisteine Capsules 375 Mg, Hard (8x1 ($28.8M, 2.3%); 5. Co-codamol 30mg/500mg Tablets (caplet) (eachtab Codeine Phosphate Hemihydrate P… ($27.0M, 2.2%)

Which ports handle pharmaceutical shipments from India to United Kingdom?

Export: NHAVA SHEVA SEA, NHAVA SHEVA SEA (INNSA1), VIZAG SEA, CHENNAI AIR, KAMARAJAR PORT. Import: LONDON GATWAY PORT, LONDON - HEATHROW, Felixstowe, Southampton, FELIXSTOWE.

Why does United Kingdom import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $1.2B corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply United Kingdom?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to United Kingdom pharmaceutical trade?

$30.5K per consignment across 40,891 shipments.

How many Indian pharmaceutical companies export to United Kingdom?

610 Indian companies. Largest: AUROBINDO PHARMA LTD with $142.0M.

How can I find verified Indian pharmaceutical suppliers for United Kingdom?

TransData Nexus covers 610 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to United Kingdom identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 40,891 verified shipments from 610 Indian exporters to 1615 United Kingdom buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

610 Exporters

1615 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to United Kingdom Pharmaceutical Export

Top Pharmaceutical Formulations — India to United Kingdom

Top Pharmaceutical Products — India to United Kingdom Trade Routes

Top Indian Exporters to United Kingdom

Port Analysis — India to United Kingdom Pharmaceutical Shipments

Indian Export Ports

United Kingdom Import Ports

Trade Statistics

Other Destinations

India–United Kingdom Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

Recent Developments

Top United Kingdom Buyers from India

Product Routes

Full Dataset Access

United Kingdom Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to United Kingdom

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and United Kingdom

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to United Kingdom Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — United Kingdom for Indian Pharma

1Market Size & Growth

2Healthcare System

3Opportunity for Indian Exporters

Competitive Landscape — India vs Other Pharmaceutical Suppliers to United Kingdom

1Competing Origins